| Treatment of Pulmonary Arterial Hypertension with Circulating Angiogenic Cells. | |
| | |
MedLine Citation:
|
PMID: 21398496 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Despite advances in the treatment of pulmonary arterial hypertension, a truly restorative therapy has not been achieved. Attention has been given to circulating angiogenic cells (CACs, also termed early endothelial progenitor cells) due to their ability to home to sites of vascular injury and regenerate blood vessels. We studied the efficacy of human CAC therapy in the treatment of pulmonary arterial hypertension at two different stages of disease severity. Cells were isolated from peripheral blood and administered to nude rats on day 14 ("early") or day 21 ("late") post monocrotaline injection. Control group received monocrotaline but no cell treatment. Disease progression was assessed using right heart catheterization and echocardiography at multiple timepoints. Survival differences, right ventricular hypertrophy (RVH) and vascular hypertrophy were analyzed at study endpoint. Quantitative PCR was performed to evaluate cell engraftment. Treatment with human CACs either at the early or late timepoints did not result in increased survival and therapy did not prevent or reduce the severity of disease compared to control. Histological analysis of RVH and vascular muscularization showed no benefit with therapy compared to control. No detectable signal was seen of human transcript in transplanted lungs at 14 or 21 days post-cell transplant. In conclusion, CAC therapy was not associated with increased survival and did not result in either clinical or histologic benefits. Future studies should be geared towards either earlier therapeutic timepoints with varying doses of unmodified CACs or genetically modified cells as a means of delivery of factors to the pulmonary arterial circulation. |
| | |
Authors:
|
Rachel Mirsky; Sarah Jahn; Juha W Koskenvuo; Richard E Sievers; Sarah M Yim; Carissa Ritner; Harold S Bernstein; Franca S Angeli; Andrew J Boyle; Teresa De Marco; Yerem Yeghiazarians |
Related Documents
:
|
20177686 - Endovascular treatment and radiographic follow-up of proximal traumatic intracranial an... 7350266 - Treatment of intracavernous and giant carotid aneurysms by combined internal carotid li... 11480266 - Mechanism of migraine and action of antimigraine medications. 15113476 - Altered arterial homeostasis and cerebral aneurysms: a review of the literature and jus... 15593296 - Anatomical variation at the saphenofemoral junction. 12630536 - Pedicled lima graft to the posterior coronary artery: which side to be anastomosed, dor... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-3-11 |
Journal Detail:
|
Title: American journal of physiology. Lung cellular and molecular physiology Volume: - ISSN: 1522-1504 ISO Abbreviation: - Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-3-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100901229 Medline TA: Am J Physiol Lung Cell Mol Physiol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
1University of California, San Francisco. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The metastasis suppressor, N-MYC downstream regulated gene 1 (NDRG1), UP-regulates P21 VIA P53-indep...
Next Document: Glucocorticoid Regulation of Human Pulmonary Surfactant Protein B (SP-B) mRNA Stability Is Independe...